Hertl M - Search Results

1

Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus?

Hertl M, Eming R, Borradori L. Hertl M, et al. Dermatology. 2007;214(4):275-7. doi: 10.1159/000100876. Dermatology. 2007. PMID: 17460396 No abstract available.

2

Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.

Hofmann S, Thoma-Uszynski S, Hunziker T, Bernard P, Koebnick C, Stauber A, Schuler G, Borradori L, Hertl M. Hofmann S, et al. Among authors: hertl m. J Invest Dermatol. 2002 Nov;119(5):1065-73. doi: 10.1046/j.1523-1747.2002.19529.x. J Invest Dermatol. 2002. PMID: 12445194 Free article.

3

BP230- and BP180-specific auto-antibodies in bullous pemphigoid.

Thoma-Uszynski S, Uter W, Schwietzke S, Hofmann SC, Hunziker T, Bernard P, Treudler R, Zouboulis CC, Schuler G, Borradori L, Hertl M. Thoma-Uszynski S, et al. Among authors: hertl m. J Invest Dermatol. 2004 Jun;122(6):1413-22. doi: 10.1111/j.0022-202X.2004.22603.x. J Invest Dermatol. 2004. PMID: 15175032 Free article.

4

Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230.

Thoma-Uszynski S, Uter W, Schwietzke S, Schuler G, Borradori L, Hertl M. Thoma-Uszynski S, et al. Among authors: hertl m. J Immunol. 2006 Feb 1;176(3):2015-23. doi: 10.4049/jimmunol.176.3.2015. J Immunol. 2006. PMID: 16424234

5

Autoimmune bullous disorders.

Eming R, Hertl M; Autoimmune Diagnostics Working Group. Eming R, et al. Among authors: hertl m. Clin Chem Lab Med. 2006;44(2):144-9. doi: 10.1515/CCLM.2006.027. Clin Chem Lab Med. 2006. PMID: 16475898 Free article. Review.

6

Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.

Eming R, Rech J, Barth S, Kalden JR, Schuler G, Harrer T, Hertl M. Eming R, et al. Among authors: hertl m. Dermatology. 2006;212(2):177-87. doi: 10.1159/000090659. Dermatology. 2006. PMID: 16484825

7

T cell control in autoimmune bullous skin disorders.

Hertl M, Eming R, Veldman C. Hertl M, et al. J Clin Invest. 2006 May;116(5):1159-66. doi: 10.1172/JCI28547. J Clin Invest. 2006. PMID: 16670756 Free PMC article. Review.

8

Immunoadsorption in pemphigus.

Eming R, Hertl M. Eming R, et al. Among authors: hertl m. Autoimmunity. 2006 Nov;39(7):609-16. doi: 10.1080/08916930600972040. Autoimmunity. 2006. PMID: 17101505 Free article. Review.

9

Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.

Veldman C, Eming R, Wolff-Franke S, Sonderstrup G, Kwok WW, Hertl M. Veldman C, et al. Among authors: hertl m. Clin Immunol. 2007 Mar;122(3):330-7. doi: 10.1016/j.clim.2006.09.014. Epub 2006 Nov 17. Clin Immunol. 2007. PMID: 17113829

10

Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).

Niedermeier A, Eming R, Pfütze M, Neumann CR, Happel C, Reich K, Hertl M. Niedermeier A, et al. Among authors: hertl m. Arch Dermatol. 2007 Feb;143(2):192-8. doi: 10.1001/archderm.143.2.192. Arch Dermatol. 2007. PMID: 17309999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

508 results

Search Page

Filters